Orrstown Financial Services (ORRF) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
3 Feb, 2026Executive summary
Achieved record annual net income of $80.9 million and diluted EPS of $4.18 for 2025, the highest in company history, with Q4 net income of $21.5 million ($1.11 per diluted share).
Profitability metrics remain at the high end of the peer group, with a robust loan pipeline and strong earnings heading into 2026.
Return on average equity for the year was 14.76% and return on average assets was 1.49%.
Maintained strong profitability and capital generation despite market challenges.
Board declared a $0.30 per share dividend, a $0.03 increase, marking the fourth increase in 18 months.
Financial highlights
Net interest margin for the year was 4.04%; for Q4, it was 4.00%, down from 4.11% in Q3.
Fee income for the year was $52.3 million, contributing 21% of total operating income; Q4 noninterest income rose to $14.4 million, driven by wealth management and swap fees.
Noninterest expenses increased to $37.4 million in Q4, mainly due to higher healthcare and professional service costs.
Loans increased to $4.02 billion, up 1.0% sequentially and 2.3% year-over-year, with Q4 loan production of $207 million.
Efficiency ratio improved to 57.5% in Q4 2025 from 69.4% in Q4 2024.
Outlook and guidance
Projected net interest margin for 2026 is 3.90%-4.00%, with potential upside if rate cuts do not materialize.
Loan growth guidance for 2026 is 5% annualized or better.
Noninterest income projected at $53M–$55M annualized; noninterest expenses at $148M–$151M annualized.
Expenses expected to run around $37 million per quarter, with flexibility for talent investments.
Confident in meeting or exceeding current analyst consensus.
Latest events from Orrstown Financial Services
- Shelf registration allows up to $200M in securities for flexible corporate funding and growth.ORRF
Registration Filing29 Jan 2026 - Q1 2025 net income and EPS surged, with strong capital and lower merger costs.ORRF
Q1 202523 Dec 2025 - Major merger, robust financials, and key governance votes highlight this year's proxy.ORRF
Proxy Filing2 Dec 2025 - Q2 2025 saw higher earnings, improved efficiency, a dividend hike, and share repurchase authorization.ORRF
Q2 202516 Nov 2025 - Q3 2025 net income hit $21.9M, with record margins, strong growth, and robust capital.ORRF
Q3 20256 Nov 2025 - Q3 2024 loss from merger costs offset by strong adjusted earnings and loan growth.ORRF
Q3 202413 Jun 2025 - Q2 net income declined, but dividend rose 15% and Codorus merger integration is on track.ORRF
Q2 202413 Jun 2025 - Q4 2024 net income rebounded, merger integration completed, and cost savings achieved.ORRF
Q4 20245 Jun 2025